6 April 2020 - 13 Nisan 5780 - י"ג ניסן ה' אלפים תש"פ
Israel-based startup GlucoMe to test diabetes-monitoring device in Vietnam E-mail

German pharmaceutical and technology company Merck KGaA signed a pilot collaboration agreement with Israelbased diabetes-monitoring startup GlucoMe Ltd. in August to test GlucoMe’s device in several hospitals in Vietnam, where it is currently being trialled.

GlucoMe develops and markets a wireless glucose and insulin monitor that records blood measurements and insulin intakes automatically and syncs with a mobile app. The patient’s personalised profile connects in real time to a digital service that includes cloud-based diabetes- management software for health professionals.

The company’s products received a CE mark (European approval), and GlucoMe is currently pursuing clearance from the US Food and Drug Administration.

According to Thai Hong Quang, the chairman of the Vietnam Association of Diabetes and Endocrinology (VADE), 5.4% of Vietnamese people – around 5 million people – have diabetes.

Please login or register to see the full article

Warning: Parameter 1 to modMainMenuHelper::buildXML() expected to be a reference, value given in /home/joomla789/domains/jewishtimesasia.org/public_html/libraries/joomla/cache/handler/callback.php on line 99
Jewish Times Asia is published by Jewish Times Asia Ltd. © Copyright 2020.
Material in the newspaper or on this site may not be used or reproduced in any form or in any way without permission from the editor.
While every effort has been made to ensure the content is true and accurate, the publisher is not responsible for any errors or omissions in the printed text.